CAT scan of brain, Alzheimer's disease (Credit: Getty Images)
Five questions on the future of Lilly’s Alzheimer’s drug, from Dunn’s legacy to ARIA
Just days ago, success in Eli Lilly’s 30-year pursuit of an Alzheimer’s disease drug seemed all but guaranteed. Now, the FDA’s 11th …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
